Transcranial Magnetic Stimulation

Prefrontal transcranial direct current stimulation induced small- to medium-sized clinical effects in cognitive and clinical metrics in youths with ADHD with no serious adverse effects, according to a study published in JAMA Network Open.

Treatment with non-invasive, personalized repetitive transcranial magnetic stimulation in those with mild to moderate Alzheimer’s resulted in a 44% slowing of disease progression at 52 weeks, according to the manufacturer.

Results from a clinical trial examining intracranial stimulation using a novel device in those with mild Alzheimer’s disease showed that treatment led to improvements in memory, cognitive function and blood flow.

Transcranial static magnetic stimulation did not significantly modify ALS disease progression at 6 months compared with sham, but long-term follow up showed an increase in tracheostomy-free survival, data show.

Significant dose-response associations were found for transcranial magnetic stimulation and transcranial direct current stimulation across several mental disorders, including schizophrenia and depression, according to research.

The FDA has granted clearance to a transcranial magnetic stimulation device as an adjunctive treatment for major depressive disorder in patients aged 15 to 21 years, according to the manufacturer.

Three weeks of 1-Hz repetitive transcranial magnetic stimulation effectively alleviated psychomotor slowing among people with schizophrenia spectrum disorder, according to a study published in JAMA Psychiatry.

PHILADELPHIA — For those with aphasia, treatment with transcranial direct current stimulation resulted in speech improvement as early as 1 week, with significant results at 5 weeks compared with sham, according to research.

We are in a crisis when it comes to mental health in Alabama. According to the National Alliance on Mental Health, one in five adults in the state lives with mental illness.

The FDA has granted 510(k) clearance to Neuronetics Inc. for its obsessive-compulsive disorder motor threshold cap technology for NeuroStar Advanced Therapy for Mental Health.